China’s DNE Group on Tuesday announced the establishment of a more than RMB 3.5 billion ($485 million) life science park fund to invest in an R&D project in Shanghai’s Pudong district.
Among the backers for the fund is a local… Read More>>
Asia real estate and outbound investment news
China’s DNE Group on Tuesday announced the establishment of a more than RMB 3.5 billion ($485 million) life science park fund to invest in an R&D project in Shanghai’s Pudong district.
Among the backers for the fund is a local… Read More>>
In today’s roundup of regional news headlines, Singaporean giant CapitaLand reveals its Geneo life science and innovation cluster to support biomedical research, and Prologis agrees to buy $3.1 billion in US warehouses from Blackstone. Also making the list, a pair… Read More>>
IGIS Asia Investment Management, the Singapore-based investment arm of South Korea’s IGIS Asset Management, has teamed up with a leading Korean biopharmaceuticals group to launch a new platform for life science real estate investments across Asia Pacific.
The venture, which… Read More>>
Singaporean sovereign wealth fund GIC is expanding its biotech portfolio by teaming up with BlackRock Alternatives Real Estate and British Airways’ New Airways Pension Scheme (NAPS) to invest in a life sciences project in London’s King’s Cross district.
Developed by… Read More>>
The US real estate platform of Gemini Investments has made its first foray into the life sciences market by picking up a biotech-oriented office building in the San Francisco Bay area for about $59.4 million, at the same time that… Read More>>
Australia’s Elanor Funds Management has reportedly received help from Malaysian asset manager Permodalan Nasional Berhad to complete the A$289 million ($214 million) recapitalisation of the Elanor Healthcare Real Estate Fund.
The capital injection will provide a full liquidity event for… Read More>>
A joint venture between Dutch pension fund manager APG Asset Management and Singapore healthcare-focused private equity firm CBC Group has made its third investment within four months by picking up an industrial site in western Shanghai’s Qingpu district.
CBC Healthcare… Read More>>
Singapore-listed CapitaLand Ascendas REIT plans to convert one of its California office buildings into a life science property after fully leasing the asset to a US pharmaceutical company.
The trust formerly known as Ascendas REIT will equip the San Diego… Read More>>
A joint venture between Dutch pension fund manager APG Asset Management and Singapore healthcare-focused private equity firm CBC Group has acquired a pair of Beijing assets at a cost of over $180 million in the latest show of confidence in… Read More>>
ESR has acquired a business park in the Shanghai biotech cluster known as Zhangjiang Pharma Valley, marking the industrial specialist’s first-ever life sciences asset.
Hong Kong-listed ESR bought the two-building campus from mainland developer Yango for an undisclosed price earlier… Read More>>